BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17997696)

  • 1. Acamprosate in the treatment of alcohol dependence: clinical and economic considerations.
    Mason BJ; Crean R
    Expert Rev Neurother; 2007 Nov; 7(11):1465-77. PubMed ID: 17997696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence.
    Mason BJ; Heyser CJ
    Expert Opin Drug Saf; 2010 Jan; 9(1):177-88. PubMed ID: 20021295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acamprosate for the treatment of alcohol dependence.
    Boothby LA; Doering PL
    Clin Ther; 2005 Jun; 27(6):695-714. PubMed ID: 16117977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects.
    Staner L; Boeijinga P; Danel T; Gendre I; Muzet M; Landron F; Luthringer R
    Alcohol Clin Exp Res; 2006 Sep; 30(9):1492-9. PubMed ID: 16930211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of alcohol-dependent outpatients with acamprosate: a clinical review.
    Mason BJ
    J Clin Psychiatry; 2001; 62 Suppl 20():42-8. PubMed ID: 11584875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis.
    Mann K; Lehert P; Morgan MY
    Alcohol Clin Exp Res; 2004 Jan; 28(1):51-63. PubMed ID: 14745302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acamprosate: A Review of Its Use in Alcohol Dependence.
    Plosker GL
    Drugs; 2015 Jul; 75(11):1255-68. PubMed ID: 26084940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acamprosate in the treatment of alcohol dependence.
    Mason BJ
    Expert Opin Pharmacother; 2005 Oct; 6(12):2103-15. PubMed ID: 16197362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acamprosate.
    Kennedy WK; Leloux M; Kutscher EC; Price PL; Morstad AE; Carnahan RM
    Expert Opin Drug Metab Toxicol; 2010 Mar; 6(3):363-80. PubMed ID: 20163323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials.
    Snyder JL; Bowers TG
    Am J Drug Alcohol Abuse; 2008; 34(4):449-61. PubMed ID: 18584575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation.
    Mason BJ; Goodman AM; Chabac S; Lehert P
    J Psychiatr Res; 2006 Aug; 40(5):383-93. PubMed ID: 16546214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for evaluating the economic value of drugs in alcohol dependence treatment.
    Schwappach D; Popova S; Mohapatra S; Patra J; Godinho A; Rehm J
    Drug Alcohol Depend; 2012 May; 122(3):165-73. PubMed ID: 21924845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pragmatic trial of acamprosate in the treatment of alcohol dependence in primary care.
    Kiritzé-Topor P; Huas D; Rosenzweig C; Comte S; Paille F; Lehert P
    Alcohol Alcohol; 2004; 39(6):520-7. PubMed ID: 15304381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acamprosate for the adjunctive treatment of alcohol dependence.
    Overman GP; Teter CJ; Guthrie SK
    Ann Pharmacother; 2003; 37(7-8):1090-9. PubMed ID: 12841823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic effects of acamprosate on markers of cerebral function in alcohol-dependent subjects administered as pretreatment and during alcohol abstinence.
    Boeijinga PH; Parot P; Soufflet L; Landron F; Danel T; Gendre I; Muzet M; Demazières A; Luthringer R
    Neuropsychobiology; 2004; 50(1):71-7. PubMed ID: 15179024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes.
    Rösner S; Leucht S; Lehert P; Soyka M
    J Psychopharmacol; 2008 Jan; 22(1):11-23. PubMed ID: 18187529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation of Campral (Acamprosate) compared to placebo in maintaining abstinence in alcohol-dependent patients.
    Annemans L; Vanoverbeke N; Tecco J; D'Hooghe D
    Eur Addict Res; 2000 Jun; 6(2):71-8. PubMed ID: 10899732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acamprosate: a review of its use in the maintenance of abstinence in patients with alcohol dependence.
    Scott LJ; Figgitt DP; Keam SJ; Waugh J
    CNS Drugs; 2005; 19(5):445-64. PubMed ID: 15907154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acamprosate. Pharmacoeconomic implications of therapy.
    Foster RH; McClellan KJ
    Pharmacoeconomics; 1999 Dec; 16(6):743-55. PubMed ID: 10724798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical review of pharmacoeconomic studies of acamprosate.
    Poldrugo F; Haeger DA; Comte S; Walburg J; Palmer AJ
    Alcohol Alcohol; 2005; 40(5):422-30. PubMed ID: 15939706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.